Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Tamsulosin for BPH with Chronic Renal Failure
NCT02033798Unknown
- Sponsor
- The Catholic University of Korea
- Start
- Feb 2014
- Primary completion
- Jan 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of tamsulosin in benign prostatic hyperplasia (BPH), sponsored by The Catholic University of Korea. Primary endpoints: Maximal flow rate at 6 months, Maximal detrusor pressure at 6 months and 3 more. Status: unknown.
02
Drugs
tamsulosin
03
Conditions
benign prostatic hyperplasia (BPH)
Beyond the preview
Go deeper on NCT02033798.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02033798.